Curis (CRIS) Cost of Revenue (2012 - 2025)
Curis (CRIS) reported Cost of Revenue of $15000.0 for Q3 2025, down 31.82% on a YoY basis from $22000.0 in Q3 2024, and down 6.25% quarter-over-quarter from $16000.0 in Q2 2025.
Curis (CRIS) Cost of Revenue (2012 - 2025) Analysis & Trends
Curis has reported Cost of Revenue for 14 years, with the latest figure at $15000.0 in Q3 2025.
- For the quarter ending Q3 2025, Cost of Revenue fell 31.82% year-over-year to $15000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (down 52.31% YoY), and the FY2025 full-year result was $45000.0, down 54.08% from the prior year.
- Cost of Revenue for Q3 2025 stood at $15000.0, down from $16000.0 in the prior quarter.
- The five-year high for Cost of Revenue was $151000.0 in Q3 2021, with the low at $12000.0 in Q2 2024.
- Historically, Cost of Revenue has averaged $58526.3 across 5 years, with a median of $54000.0 in 2023.
- The largest YoY upside for Cost of Revenue was 95.83% in 2024 against a maximum downside of 83.78% in 2024.
- Curis' Cost of Revenue stood at $124000.0 in 2021, then plunged by 42.74% to $71000.0 in 2022, then decreased by 23.94% to $54000.0 in 2023, then tumbled by 68.52% to $17000.0 in 2024, then dropped by 11.76% to $15000.0 in 2025.
- The last three Cost of Revenue figures came in at $15000.0 (Q3 2025), $16000.0 (Q2 2025), and $14000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 2.05 Mn |
| 10 | Curis | 8.27 Mn | -6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 74,000.00 |
| Jun 30, 2023 | 74,000.00 |